These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1794165)

  • 1. Effective control of patients with porphyria cutanea tarda by measuring plasma uroporphyrin.
    Adjarov D; Kerimova M
    Clin Exp Dermatol; 1991 Jul; 16(4):254-7. PubMed ID: 1794165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of plasma uroporphyrin during treatment and long-term follow-up of patients with Porphyria cutanea tarda.
    Adjarov DG; Kerimova MA
    Clin Chim Acta; 1989 May; 181(2):143-50. PubMed ID: 2736777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination therapy of porphyria cutanea tarda using chloroquine and bloodletting therapy].
    Horkay I; Nagy E
    Z Hautkr; 1980 Jun; 55(12):813-6. PubMed ID: 7415362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment on plasma uroporphyrin levels in cutaneous hepatic porphyria.
    Allen BR; Parker S; Thompson GG; Moore MR; Darby FJ; Hunter JA
    Br J Dermatol; 1975 Jul; 93(1):37-42. PubMed ID: 1191527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Porphyria cutanea tarda in a chronic hemodialysis patient].
    Kano T; Yamane Y; Suzuki M; Yaoita H
    Nihon Hifuka Gakkai Zasshi; 1989 Jun; 99(7):819-26. PubMed ID: 2685417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Porphyria cutanea uraemica: an obligate systemic disease in chronic kidney insufficiency?].
    Senger E; Bernd A; Kachel HG; Schoeppe W; Holzmann H
    Hautarzt; 1991 Dec; 42(12):764-9. PubMed ID: 1765490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron metabolism in porphyria cutanea tarda.
    Reizenstein P; Höglund S; Landegren J; Carlmark B; Forsberg K
    Acta Med Scand; 1975; 198(1-2):95-9. PubMed ID: 1166830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis-related porphyria cutanea tarda--treatment failure with charcoal hemoperfusion.
    McColl KE; Simpson K; Laiwah AY; Thompson GG; McDougall A; Moore MR
    Photodermatol; 1986 Jun; 3(3):169-73. PubMed ID: 3529056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloroquine in treatment of porphyria cutanea tarda. Long-term efficacy of combined phlebotomy and high-dose chloroquine therapy.
    Wennersten G; Ros AM
    Acta Derm Venereol Suppl (Stockh); 1982; 100():119-23. PubMed ID: 6962628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
    Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
    Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic action of uroporphyrin on the complement system in porphyria cutanea tarda.
    Meurer M; Schulte C; Weiler A; Goerz G
    Arch Dermatol Res; 1985; 277(4):293-8. PubMed ID: 3923948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)].
    Leonhardi G; Klähn KH; Gürenci J
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):43-6. PubMed ID: 401939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload.
    Valls V; Ena J; Enríquez-De-Salamanca R
    J Dermatol Sci; 1994 Jun; 7(3):169-75. PubMed ID: 7918235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinic and treatment of porphyria cutanea tarda (author's transl)].
    Goerz G
    Dermatologica; 1979; 159(5):393-9. PubMed ID: 488497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda and HIV-1 infection. 2 new cases].
    el Sayed F; Viraben R; Bazex J; Gorguet B
    Ann Dermatol Venereol; 1993; 120(6-7):455-7. PubMed ID: 7904142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.